2 studies found for:    19273785 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy and Safety Trial of Intravitreal Injections Combined With PRP for the Treatment of CSME Secondary to Diabetes Mellitus (DAVE)
Condition: Diabetic Macular Edema
Interventions: Drug: 0.3 mg ranibizumab;   Procedure: Targeted Pan Retinal Photocoagulation
2 Completed
Has Results
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Procedure: Standard of Care Group;   Drug: 1mg triamcinolone acetonide;   Drug: 4mg triamcinolone acetonide

Indicates status has not been verified in more than two years